- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens Ultrasound takes on risk-sharing
While many medical imaging vendors talk about partnering withcustomers, one ultrasound vendor believes that a financial risk-sharingarrangement can also prove profitable. Siemens Ultrasound of Issaquah, WA, announced in January thatit has reached an
While many medical imaging vendors talk about partnering withcustomers, one ultrasound vendor believes that a financial risk-sharingarrangement can also prove profitable.
Siemens Ultrasound of Issaquah, WA, announced in January thatit has reached an equipment purchasing agreement with the ClevelandClinic Foundation that will allow CCF to pay for new scannerson a sliding fee based on equipment usage.
Under the exclusive five-year agreement, Siemens will provideCCF with an entirely new ultrasound department, consisting initiallyof six Sonoline Elegra and two Sonoline Versa ultrasound systems.Siemens will also service and upgrade the new scanners and providemore systems as CCF's needs dictate, according to the company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
